The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT

NCT02376803 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

217

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Thrombus Due to Heart Valve Prosthesis
Deep Venous Thrombosis
Thromboembolism
DVT

Interventions

DRUG: Warfarin

Sponsor

University of Alberta

Collaborators

[object Object]